Eledon Pharmaceuticals (ELDN) Current Leases (2019 - 2026)

Eledon Pharmaceuticals (ELDN) has 8 years of Current Leases data on file, last reported at $369000.0 in Q1 2026.

• Quarterly Current Leases rose 13.54% year-over-year to $369000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $369000.0 (up 13.54% YoY) and the FY2025 annual result came in at $358000.0, up 14.01% from the prior year.
• Current Leases grew to $369000.0 in Q1 2026, from $358000.0 in the prior quarter.
• In the past five years, Current Leases ranged from a high of $396000.0 in Q3 2023 to a low of $186000.0 in Q3 2024.
• A 5-year average of $335058.8 and a median of $346000.0 in 2025 frame the typical range for Current Leases.
• Annual changes were most pronounced in 2022 — Current Leases soared 238.14% — and 2024, when it sank 53.03%.
• Tracing ELDN's Current Leases over 5 years: stood at $363000.0 in 2022, then advanced by 5.51% to $383000.0 in 2023, then fell by 18.02% to $314000.0 in 2024, then increased by 14.01% to $358000.0 in 2025, then grew by 3.07% to $369000.0 in 2026.
• The last three Current Leases figures came in at $369000.0 (Q1 2026), $358000.0 (Q4 2025), and $346000.0 (Q3 2025), per Business Quant data.